Genetic complexity alters drug susceptibility of asexual and gametocyte stages of Plasmodium falciparum to antimalarial candidates

2Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Malaria elimination requires interventions able to target both the asexual blood stage (ABS) parasites and transmissible gametocyte stages of Plasmodium falciparum. Lead antimalarial candidates are evaluated against clinical isolates to address key concerns regarding efficacyand to confirmthat the current, circulating parasites from endemic regions lack resistance against these candidates. While this has largely been performed on ABS parasites, limited data are available on the transmission-blocking efficacyof compounds with multistage activity. Here, we evaluated the efficacyof lead antimalarial candidates against both ABS parasites and late-stage gametocytes side-by-side, against clinical P. falciparum isolates from southern Africa. We additionally correlated drug efficacyto the genetic diversity of the clinical isolates as determined with a panel of well-characterized, genome-spanning microsatellite markers. Our data indicate varying sensitivities of the isolates to key antimalarial candidates, both for ABS parasites and gametocyte stages. While ABS parasites were efficientlykilled, irrespective of genetic complexity, antimalarial candidates lost some gametocytocidal efficacywhen the gametocytes originated from genetically complex, multiple-clone infections. This suggests a fitnessbenefitto multiclone isolates to sustain transmission and reduce drug susceptibility. In conclusion, this is the firststudy to investigate the efficacyof antimalarial candidates on both ABS parasites and gametocytes from P. falciparum clinical isolates where the influenceof parasite genetic complexity is highlighted, ultimately aiding the malaria elimination agenda.

References Powered by Scopus

Invasion of red blood cells by malaria parasites

703Citations
N/AReaders
Get full text

Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination

546Citations
N/AReaders
Get full text

Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: Polymerase chain reaction methods for surveillance in Africa

533Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The Tuberculosis Drug Candidate SQ109 and Its Analogs Have Multistage Activity against Plasmodium falciparum

1Citations
N/AReaders
Get full text

Beninese Plant Extracts with Antiplasmodial Activity Select New Allele Variants Msp 1 and Msp2 in Plasmodium falciparum

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Greyling, N., Van Der Watt, M., Gwarinda, H., van Heerden, A., Greenhouse, B., Leroy, D., … Birkholtz, L. M. (2024). Genetic complexity alters drug susceptibility of asexual and gametocyte stages of Plasmodium falciparum to antimalarial candidates. Antimicrobial Agents and Chemotherapy, 68(3). https://doi.org/10.1128/aac.01291-23

Readers over time

‘24‘25036912

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

67%

Researcher 2

33%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 3

43%

Medicine and Dentistry 2

29%

Environmental Science 1

14%

Immunology and Microbiology 1

14%

Save time finding and organizing research with Mendeley

Sign up for free
0